Medicines RVO/2845/2024 in the range of IMMUNOPREPARATIONS, CYTOSTATICS, BLOOD SUBSTITUTES, BLOOD DERIVATIVES and ANTIHORMONES for the needs of FNsP F. D. Roosevelt Banská Bystrica

This tender concerns the procurement of medicines for the F. D. Roosevelt University Hospital in Banská Bystrica, Slovakia, under reference number RVO/2845/2024. The scope of the contract encompasses several critical categories of pharmaceuticals, including immunopreparations, cytostatics, substitutio sanguinis (blood substitutes), blood derivatives, and antihormones. The procurement is structured into 85 distinct lots. Bidders have the flexibility to submit offers for the entire scope of the contract, covering all 85 lots, or to bid on individual lots or a selection of multiple lots. The detailed breakdown of each lot is provided in Section C - Description of the Subject of the Contract, within Appendix No. 1 of the tender documentation. While the contract is divided into 85 parts, this specific detail is not listed in the standard sections of the procurement notice due to the time and administrative complexity involved in publishing all individual lots. Interested parties are advised to consult the full tender documents for a comprehensive understanding of the specific requirements and lot definitions. This procurement aims to ensure the continuous supply of essential medications to the hospital, supporting its critical medical services.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and Medical Equipment. Located in Slovakia, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 17.8 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.